Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection

Journal of Medical Virology

Volumn 78, Issue 9, 2006, Pages 1190-1197

  Quiroga, Juan A ^a   Llorente, Silvia ^a   Castillo, Immaculada ^a   Rodríguez Iñigo, Elena ^a   López Alcorocho, Juan Manuel ^a   Pardo, Margarita ^a   Carreño, Vicente ^a  

^a Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

Author keywords

Asymptomatic aviremic anti HCV carrier; CD4+ and CD8 + T cell responses; HCV persistence; Hepatitis C virus (HCV); Sustained virological response to antiviral therapy

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; T LYMPHOCYTE; VIRUS CARRIER; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HEPACIVIRUS; HEPATITIS C; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LIVER; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, VIRAL; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 33746792336     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20680     Document Type: Article

References (47)

1. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, Lau D, Hoofnagle JH. 1997. Hepatitis C in asymptomatic blood donors. Hepatology 26:29S-33S.
2. Bowen DG, Walker CM. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952.
3. Brooks DG, Teyton L, Oldstone MB, McGavern DB. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol 79:10514-10527.
4. Carreño V, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Quiroga JA, Pardo M. 2005. Hepatitis C virus persists and replicates in the liver of the majority of sustained responder patients to antiviral treatment [abstract 220]. In: Program and abstracts of the 56th Annual Meeting of the American Association for the Study of Liver Diseases (San Francisco) 42:284A.
5. Carreño V, Pardo M, López-Alcorocho JM, Rodríguez- Iñigo E, Bartolomé J, Castillo I. 2006. Detection of hepatitis C virus RNA in the liver of healthy, anti-HCV positive serum HCV-RNA negative subjects with normal alanine aminotransferase levels. J Infect Dis 194:53-60.
6. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, Salas C, Jimenez-Heffernan JA, Perez-Mota A, Graus J, Lopez-Alcorocho JM, Carreño V. 2004. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189:7-14.
7. Castillo I, Rodríguez-Iñigo E, Bartolomé J, de Lucas S, Ortiz-Movilla N, Lopez-Alcorocho JM, Pardo M, Carreño V. 2005. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54:682-685.
8. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P, Walker CM. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449.
9. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346-355.
10. + T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76:12584-12595.
11. Day CL, Seth NP, Lucas M, Appel H, Gauthier L, Lauer GM, Robbins GK, Szczepiorkowski ZM, Casson DR, Chung RT, Bell S, Harcourt G, Walker BD, Klenerman P, Wucherpfennig KW. 2003. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112:831-842.
12. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
13. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71:6011-6019.
14. Gale M, Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945.
15. + T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol 79:12425-12433.
16. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM, Walker CM. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-662.
17. Hultgren C, Desombere I, Leroux-Roels G, Quiroga JA, Carreño V, Nilsson B, Weiland O, Sällberg M. 2004. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses. J Hepatol 40:971-978.
18. Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW. 2002. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123:1070-1083.
19. Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, Rasenack J, Nakano T, Robertson B, Ismail A, Koziel MJ. 2004. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 78:12252-12258.
20. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. 1997. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 176:859-866.
21. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Bobbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman P. 2004. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127:924-936.
22. + T-cell responses in acute hepatitis C virus infection and early therapy. J Virol 79:12979-12988.
23. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512.
24. Lee WM, Poison JE, Carney DS, Sahin B, Gale M. 2005. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: Evidence for an occult viral reservoir. J Infect Dis 192:1088-1092.
25. López-Labrador FX, He XS, Berenguer M, Cheung RC, Wright TL, Greenberg HB. 2004. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. J Immunol Methods 287:91-99.
26. Martín J, Navas S, Quiroga JA, Colucci G, Pardo M, Carreño V. 1998. Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection. J Med Virol 54:265-270.
27. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. 2002. Protection against persistence of hepatitis C. Lancet 359:1478-1483.
28. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98:706-714.
29. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. 2004. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78:5867-5874.
30. Radkowski M, Horban A, Gallegos-Orozco JF, Pawelczyk A, Jablonska J, Wilkinson J, Adair D, Laskus T. 2005a. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels. J Infect Dis 191:1730-1733.
31. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. 2005b. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114.
32. Rehermann B, Nascimbeni M. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5:215-229.
33. + T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J Hepatol 36:408-416.
34. + T-cell responses in hemodialysis patients with hepatitis C virus infection. J Med Virol 72:66-74.
35. Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Ortíz-Movilla N, Pardo M, Carreño V. 2005. Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels. J Mol Diagn 7:535-543.
36. Scheuer PJ. 1991. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 13:372-374.
37. + Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175: 3603-3613.
38. + T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162:6681-6689.
39. Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, Klenerman P. 2005. T-cell responses and previous exposure to hepatitis virus in indeterminate blood donors. Lancet 365:327-329.
40. + T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197:1645-1655.
41. + T-cell failure during chronic hepatitis C virus infection. Hepatology 42:828-837.
42. + T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol 64:497-504.
43. Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases. 2004. Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147-1171.
44. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406.
45. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, Chisari FV. 2002. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 99:15661-15668.
46. Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM. 2003. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37:1189-1198.
47. + T cells in chronic hepatitis C virus infection. J Immunol 169:3447-3458.